ADVANCED GYNECOLOGICAL MALIGNANCIES
Clinical trials for ADVANCED GYNECOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GYNECOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED GYNECOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BRY812 targets Hard-to-Treat gynecologic cancers in early trial
Disease control Not yet recruitingThis study tests a new drug called BRY812 in people with advanced gynecologic cancers (ovarian, endometrial, or ovarian clear cell) that have a specific marker called LIV-1. The goal is to see if the drug can shrink tumors. About 56 participants will receive the drug, and researc…
Matched conditions: ADVANCED GYNECOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
New drug combo aims to shrink advanced ovarian, cervical, and endometrial tumors
Disease control Not yet recruitingThis study tests a new drug called SKB518, given alone or with standard chemotherapy, in 290 people with advanced ovarian, cervical, or endometrial cancer. The goal is to see if it can shrink tumors or slow cancer growth. Participants must be 18–75 years old and in good enough he…
Matched conditions: ADVANCED GYNECOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:18 UTC